Arthur D. Riggs, the diabetes expert who developed the technology that led to the first human synthetic insulin for the treatment of diabetes, died March 23 at age 82 after battling cancer. A biotechnology pioneer and a longtime leader at City of Hope, Riggs served as director emeritus of Beckman Research Institute of City of Hope...
Researchers from City of Hope have developed a “plug-and-play” technology that adds engineered molecules to chimeric antigen receptor T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer. The preclinical study offers a more flexible way to help CAR T cells keep pace with mutating tumors.
